Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canadian Clinical Cannabinoids is a Canadian cannabis company operating a licensed production, processing, and analytical testing business in Ontario. The company appears to market itself both under its corporate name and through the TripC Brands brand-house identity, with a portfolio of adult-use cannabis brands and products sold in Canada. Historically, the business emphasized cannabinoid research, analytical testing, and encapsulated cannabinoid medicine, while more recent materials focus on licensed production, co-manufacturing, processing, and brand commercialization. Publicly available information indicates the company is active and Health Canada-authorized for cannabis-related activities. For biotech-style diligence, it is better characterized as a commercial cannabis operator with testing and product-development capabilities than as a traditional clinical-stage biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Clinical Cannabinoids.